3 Reasons to Buy Intuitive Surgical Stock Near Its 52-Week Low

Group 1 - Intuitive Surgical has faced challenges in the past year, with a 17% decline in stock price since January, largely due to the impact of tariffs [1] - The company specializes in robotic-assisted surgery (RAS) devices, with the da Vinci system being its most recognized product [3] - RAS devices are considered the future of surgery, offering improved precision, faster recovery times, and shorter hospital stays for patients [4][5] Group 2 - The installed base of Intuitive Surgical's systems reached 10,488, marking a 14% year-over-year increase, while da Vinci procedure volume grew by 17% [6] - The global surgical market is projected to be worth $3.35 trillion in 2024, with RAS currently accounting for only $11.2 billion, indicating significant growth potential [7] - The aging population and increasing demand for minimally invasive procedures present long-term opportunities for Intuitive Surgical [8] Group 3 - Intuitive Surgical's strong market position and competitive advantages suggest it can navigate current challenges effectively [9]